Nimbex and Lip oedema - a phase IV clinical study of FDA data


Lip oedema is reported only by a few people who take Nimbex.

The phase IV clinical study analyzes which people take Nimbex and have Lip oedema. It is created by eHealthMe based on reports of 1,431 people who have side effects while taking Nimbex from the FDA, and is updated regularly.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Nov, 26, 2022

1,431 people reported to have side effects when taking Nimbex.
Among them, 4 people (0.28%) have Lip oedema.

What is Nimbex?

Nimbex has active ingredients of cisatracurium besylate. eHealthMe is studying from 1,431 Nimbex users for its effectiveness, alternative drugs and more.

What is Lip oedema?

Lip oedema (swelling of lip) is found to be associated with 734 drugs and 474 conditions by eHealthMe.

Number of Nimbex and Lip oedema reports submitted per year:

Could Nimbex cause Lip oedema?

Time on Nimbex when people have Lip oedema *:

  • < 1 month: 100 %
  • 1 - 6 months: 0.0 %
  • 6 - 12 months: 0.0 %
  • 1 - 2 years: 0.0 %
  • 2 - 5 years: 0.0 %
  • 5 - 10 years: 0.0 %
  • 10+ years: 0.0 %

Gender of people who have Lip oedema when taking Nimbex *:

  • female: 25 %
  • male: 75 %

Age of people who have Lip oedema when taking Nimbex *:

  • 0-1: 50 %
  • 2-9: 0.0 %
  • 10-19: 0.0 %
  • 20-29: 0.0 %
  • 30-39: 0.0 %
  • 40-49: 0.0 %
  • 50-59: 25 %
  • 60+: 25 %

Common drugs people take besides Nimbex *:

  1. Diprivan: 3 people, 75.00%
  2. Sufentanil Citrate: 2 people, 50.00%
  3. Rocephin: 2 people, 50.00%
  4. Xarelto: 1 person, 25.00%
  5. Ketamine Hcl: 1 person, 25.00%
  6. Actrapid: 1 person, 25.00%
  7. Dexamethasone: 1 person, 25.00%
  8. Ephedrine: 1 person, 25.00%
  9. Gentamicin: 1 person, 25.00%
  10. Heparin: 1 person, 25.00%

Common side effects people have besides Lip oedema *:

  1. Face Oedema (swelling of face): 3 people, 75.00%
  2. Tongue Oedema (swelling of tongue): 2 people, 50.00%
  3. Rashes (redness): 2 people, 50.00%
  4. Eyelid Oedema (eyelids are swollen and contain excessive fluid): 2 people, 50.00%
  5. Rash Macular (small, flat red spots): 1 person, 25.00%
  6. Oxygen Saturation Decreased: 1 person, 25.00%
  7. Oedema Peripheral (superficial swelling): 1 person, 25.00%
  8. Laryngospasm (an uncontrolled/involuntary muscular contraction of larynx): 1 person, 25.00%
  9. Hypotension (abnormally low blood pressure): 1 person, 25.00%
  10. Arrhythmias (irregular heartbeat): 1 person, 25.00%

Common conditions people have *:

  1. Anaesthesia: 2 people, 50.00%

* Approximation only. Some reports may have incomplete information.

Do you take Nimbex and have Lip oedema?

Check whether Lip oedema is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Lip oedema and when was it recovered:

Expand to all the drugs that have ingredients of cisatracurium besylate:

Alternative drugs to, pros and cons of Nimbex:

Common Nimbex side effects:

Browse all side effects of Nimbex:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Lip oedema treatments and more:

COVID vaccines that are related to Lip oedema:

Common drugs associated with Lip oedema:

All the drugs that are associated with Lip oedema:

Common conditions associated with Lip oedema:

All the conditions that are associated with Lip oedema:

How the study uses the data?

The study uses data from the FDA. It is based on cisatracurium besylate (the active ingredients of Nimbex) and Nimbex (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).


WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.

Recent studies on eHealthMe: